PROCYSBI(R) Receives Positive Opinion for Orphan Drug Exclusivity From the ... NASDAQ However, poor adherence to therapy has been a major challenge resulting in poor sustained control of cystine levels, and patients consequently experience poor clinical outcomes, including kidney insufficiency leading to dialysis and kidney ... |
